Farms.com Home   News

Colorado Man First In U.S. To Test Positive For Bird Flu

Colorado Man First In U.S. To Test Positive For Bird Flu

A Colorado man who was culling poultry with suspected bird flu has tested positive for the disease. It’s the first-known human case in the nation, but officials say the risk to the public is low.

Health officials detected H5N1 influenza – known as avian flu – in the nose of a 40-year-old man who was culling the chickens in Montrose County as part of a prison pre-release work program.

When they tested him a second time, though, he was negative for the virus. Officials say a piece of the virus may have gotten in his nose from the chickens and was picked up by the first test, but he wasn't actually infected by it. The man is largely asymptomatic and on antiviral drugs.

Officials say human infections with avian flu are rare and there is a low risk of person-to-person spread. But they urge people to avoid birds that appear ill or are dead.

Poultry is safe to eat because cooking the meat to an internal temperature of 165° F kills bacteria and viruses, including H5N1.

Click here to see more...

Trending Video

Inside the Battle Against Streptococcus suis - Dr. Mariela Segura

Video: Inside the Battle Against Streptococcus suis - Dr. Mariela Segura

In this special rerun episode of The Swine it Podcast Show Canada, Dr. Mariela Segura from the University of Montreal explains the current challenges and future perspectives of Streptococcus suis vaccines. She discusses the impact of the pathogen on pig health, antibiotic resistance, zoonotic risks, and the latest vaccine innovations. Gain insights into how the swine industry can improve disease control. Listen now on all major platforms! "Streptococcus suis is not only a major economic concern in the swine industry but also a zoonotic pathogen." Meet the guest: Dr. Mariela Segura / mariela-segura-442a8425a is a full professor at the Faculty of Veterinary Medicine at the University of Montreal and the director of the Swine and Poultry Infectious Diseases Center (CRIPA). She earned her master's and Ph.D. from the Université de Montréal.